Disparities in the Prevalence of Diagnosed DiabetesUnited States, 19992002 and 20112014
The development of dependable biomarkers to estimate therapy response and enhance patient selection constitutes another substantial unmet need, since individual responses to GLP-1 treatments might differ markedly
Youll fill out a medical questionnaire, and in some cases, do a remote video consult
Based on the available trial data and patterns observed with related incretin-based therapies, fatigue associated with retatrutide is thought to be most pronounced during the dose escalation phase
We look for medication interactions, gallbladder symptoms, gastroparesis red flags, pregnancy when relevant, and other conditions that may need separate evaluation
And their benefits go beyond weight loss alone as theyve shown to improve heart health, kidney health, and even sleep apnea